GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bharat Rasayan BHARATRAS.NS · INR

Materials · NSE · 🇮🇳 India

Compare

970.35

-0.01%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Bharat Rasayan

Its shares trade on NSE under the ticker BHARATRAS.NS. It has been listed since 1 February 1993. In the fiscal year to 31 March 2026, it reported revenue of ₹12.42bn and net income of ₹1.46bn. At that date it held total assets of ₹14.33bn and shareholders' equity of ₹12.75bn.

Bharat Rasayan Ltd. engages in the business of agrochemicals. The company is headquartered in New Delhi, Delhi. The Company’s products include Insecticides, which consists of Zeta Cypermethrin, Alphacypermethrin, Bifenthrin, Cypermethrin, Acetamiprid, Diafenthiuron, Bifnthrin, Fenvalerate, Permethrin, Thiamethoxam, Imidalcloprid and Fipronil; Herbicides, which include Chlorimuron Ethyl, Clodinafop Propargyl, Diuron, Metsulfuron Methyl, Metribuzin, Pendimethalin and Sulfosulfuron; Fungicides, which include Myclobutanil, Tebuconazole and Difenoconazole, and Intermediates, which include Meta Phenoxy Benzaldehyde, Meta Phenoxy Benzyl Alcohol, Para Chloro Benzyl Cyanide and Cypermethrin Acid Chloride. The firm's plants are located at Rohtak, Haryana and Bharuch, Gujarat. The firm's plant at Haryana, has a capacity of 4,260 metric tons (MT) per annum and also facilities for bulk packaging of formulations.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Materials
Industry
Chemicals
Listed since
1 Feb 1993
Employees
797

Leadership

Pay as last reported

  • Shri. Sat GuptaExecutive Chairman of the Board, Managing Director₹3.3m
  • Shri. Rajender GuptaChief Executive Officer, Whole-Time Director, since 1989₹1.2m
  • Shri. Rakesh VermaChief Financial Officer₹3.0m
  • Ms. Nikita ChadhaCompliance Officer, Company Secretary₹1.5m
  • Shri. Ajay GuptaWhole-Time Director, since 2008₹9.7m
  • Shri. Mahabir GuptaWhole-Time Director, since 1989₹1.5m
  • Sri. Kamleshwar UniyalWhole-Time Director, since 2019₹4.6m
  • Shri. Ankit AggarwalNon-Executive Independent Director, since 2022
  • Shri. Suresh GargNon-Executive Independent Director
  • Smt. Mukta GuptaNon-Executive Independent Director
  • Shri. Rajesh GuptaNon-Executive Independent Director, since 2024
  • Shri. Naman JainNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
35
Environment
47
Social
40
Governance
18
Direct emissions (scope 1)
34,074.18 t
Energy emissions (scope 2)
30,278.38 t
Women in the workforce
2.21%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Bharat Rasayan Ltd employs 797 full-time employees in New Delhi, India.
  • The company produces 12 insecticides including Zeta Cypermethrin and Fipronil.
  • Bharat Rasayan's Rohtak plant has a 4,260 MT annual capacity for agrochemicals.

Weaknesses

  • The company's plant in Bharuch, Gujarat, lacks specified production capacity details.
  • Bharat Rasayan Ltd has no mention of international market presence beyond India.
  • Bharat Rasayan's product range does not include organic or eco-friendly agrochemicals.

Opportunities

  • Expanding into the Indian agricultural sector with new herbicide products like Chlorimuron Ethyl.
  • Increasing demand for fungicides such as Tebuconazole in Indian farming.
  • Growing market for intermediates like Meta Phenoxy Benzaldehyde in chemical manufacturing.

Threats

  • Competition from other Indian chemical firms in the agrochemical sector.
  • Regulatory changes affecting pesticide usage in India's agricultural policies.
  • Overreliance on domestic market without global expansion strategies.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.